Skip to main content
Top
Published in: Italian Journal of Pediatrics 1/2023

Open Access 01-12-2023 | Kawasaki Disease | Research

Predictors and a novel predictive model for intravascular immunoglobulin resistance in Kawasaki disease

Authors: Junjie Wang, Xiaohui Huang, Donghao Guo

Published in: Italian Journal of Pediatrics | Issue 1/2023

Login to get access

Abstract

Background

Early identification of intravenous immunoglobulin (IVIG) resistance contributes to better management of Kawasaki disease (KD). This study aims to establish an effective prediction model for IVIG resistance in the Chinese population.

Methods

A total of 658 eligible patients diagnosed with KD were enrolled in this study, with 461 in the training cohort and 197 in the validation cohort. The demographic characteristics and potential risk factors were compared between IVIG-responsive and resistant groups. Predictors were selected by the Akaike information criterion. The nomogram’s performance was evaluated by calibration curve, decision curve analysis, and operating characteristic curve.

Results

White blood cell counts (WBC), neutrophil-lymphocyte ratio (N/L ratio), hematocrit (HCT), albumin (ALB), total bilirubin (TBIL), lactate dehydrogenase (LDH), and creatinine (Cr) were detected as predictors of IVIG resistance. A predictive nomogram incorporating these predictors was constructed using the training cohort. The calibration curve and decision curve analysis showed good discrimination and calibration of the proposed nomogram in both training and validation sets, and the area under the receiver operating characteristic curve (AUROC) in both sets was 75.8% and 74.2%, respectively.

Conclusion

This study identified WBC, N/L ratio, HCT, ALB, TBIL, LDH, and Cr as predictors for IVIG resistance in patients with KD. The proposed novel nomogram with a high level of accuracy and reliability may benefit clinical decision-making upon treatment initiation.
Literature
1.
go back to reference Gorelik M, Chung SA, Ardalan K, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of Kawasaki Disease. Arthritis Rheumatol. 2022;74(4):586–96.CrossRefPubMed Gorelik M, Chung SA, Ardalan K, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of Kawasaki Disease. Arthritis Rheumatol. 2022;74(4):586–96.CrossRefPubMed
2.
go back to reference McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.CrossRefPubMed McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.CrossRefPubMed
4.
go back to reference Fukazawa R, Kobayashi J, Ayusawa M, et al. JCS/JSCS 2020 Guideline on diagnosis and management of Cardiovascular Sequelae in Kawasaki Disease. Circ J. 2020;84(8):1348–407.CrossRefPubMed Fukazawa R, Kobayashi J, Ayusawa M, et al. JCS/JSCS 2020 Guideline on diagnosis and management of Cardiovascular Sequelae in Kawasaki Disease. Circ J. 2020;84(8):1348–407.CrossRefPubMed
5.
go back to reference Fabi M, Andreozzi L, Corinaldesi E, et al. Inability of asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an italian cohort. Eur J Pediatr. 2019;178(3):315–22.CrossRefPubMed Fabi M, Andreozzi L, Corinaldesi E, et al. Inability of asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an italian cohort. Eur J Pediatr. 2019;178(3):315–22.CrossRefPubMed
6.
go back to reference Sleeper LA, Minich LL, McCrindle BM, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831–5. e833.CrossRefPubMed Sleeper LA, Minich LL, McCrindle BM, et al. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011;158(5):831–5. e833.CrossRefPubMed
7.
go back to reference Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606–12.CrossRefPubMed Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606–12.CrossRefPubMed
8.
go back to reference Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237–40.CrossRefPubMed Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237–40.CrossRefPubMed
9.
go back to reference Li X, Chen Y, Tang Y, et al. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases. Eur J Pediatr. 2018;177(8):1279–92.CrossRefPubMedPubMedCentral Li X, Chen Y, Tang Y, et al. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases. Eur J Pediatr. 2018;177(8):1279–92.CrossRefPubMedPubMedCentral
10.
go back to reference Dziak JJ, Coffman DL, Lanza ST, Li R, Jermiin LS. Sensitivity and specificity of information criteria. Brief Bioinform. 2020;21(2):553–65.CrossRefPubMed Dziak JJ, Coffman DL, Lanza ST, Li R, Jermiin LS. Sensitivity and specificity of information criteria. Brief Bioinform. 2020;21(2):553–65.CrossRefPubMed
11.
go back to reference Hamada H, Suzuki H, Onouchi Y, et al. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial. Lancet. 2019;393(10176):1128–37.CrossRefPubMed Hamada H, Suzuki H, Onouchi Y, et al. Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial. Lancet. 2019;393(10176):1128–37.CrossRefPubMed
12.
13.
go back to reference Ae R, Abrams JY, Maddox RA, et al. Corticosteroids added to initial intravenous immunoglobulin treatment for the Prevention of Coronary Artery Abnormalities in high-risk patients with Kawasaki Disease. J Am Heart Assoc. 2020;9(17):e015308.CrossRefPubMedPubMedCentral Ae R, Abrams JY, Maddox RA, et al. Corticosteroids added to initial intravenous immunoglobulin treatment for the Prevention of Coronary Artery Abnormalities in high-risk patients with Kawasaki Disease. J Am Heart Assoc. 2020;9(17):e015308.CrossRefPubMedPubMedCentral
14.
go back to reference Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007;166(2):131–7.CrossRefPubMed Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007;166(2):131–7.CrossRefPubMed
15.
go back to reference Liu J, Zhang J, Huang H, et al. A machine learning model to Predict Intravenous immunoglobulin-resistant Kawasaki Disease Patients: a retrospective study based on the Chongqing Population. Front Pediatr. 2021;9:756095.CrossRefPubMedPubMedCentral Liu J, Zhang J, Huang H, et al. A machine learning model to Predict Intravenous immunoglobulin-resistant Kawasaki Disease Patients: a retrospective study based on the Chongqing Population. Front Pediatr. 2021;9:756095.CrossRefPubMedPubMedCentral
16.
go back to reference Huang H, Jiang J, Shi X, et al. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China. Ann Med. 2022;54(1):442–53.CrossRefPubMedPubMedCentral Huang H, Jiang J, Shi X, et al. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China. Ann Med. 2022;54(1):442–53.CrossRefPubMedPubMedCentral
17.
go back to reference Muto T, Masuda Y, Numoto S, et al. White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease. Glob Pediatr Health. 2019;6:2333794X19884826.PubMedPubMedCentral Muto T, Masuda Y, Numoto S, et al. White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease. Glob Pediatr Health. 2019;6:2333794X19884826.PubMedPubMedCentral
18.
go back to reference Gonzalez Fernandez A, de la Rubia Orti JE, Franco-Martinez L, Ceron JJ, Mariscal G, Barrios C. Changes in salivary levels of creatine kinase, Lactate dehydrogenase, and Aspartate aminotransferase after playing Rugby Sevens: the influence of gender. Int J Environ Res Public Health. 2020;17:21.CrossRef Gonzalez Fernandez A, de la Rubia Orti JE, Franco-Martinez L, Ceron JJ, Mariscal G, Barrios C. Changes in salivary levels of creatine kinase, Lactate dehydrogenase, and Aspartate aminotransferase after playing Rugby Sevens: the influence of gender. Int J Environ Res Public Health. 2020;17:21.CrossRef
19.
go back to reference Piram M, Darce Bello M, Tellier S, et al. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-asian patients with Kawasaki disease. Sci Rep. 2020;10(1):3125.CrossRefPubMedPubMedCentral Piram M, Darce Bello M, Tellier S, et al. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-asian patients with Kawasaki disease. Sci Rep. 2020;10(1):3125.CrossRefPubMedPubMedCentral
20.
go back to reference Sauerbrei W, Royston P. Continuous variables: to categorize or to model. Paper presented at: The 8th International Conference on Teaching Statistics–Data and Context in statistics education: Towards an evidence based society. International Statistical Institute, Voorburg2010. Sauerbrei W, Royston P. Continuous variables: to categorize or to model. Paper presented at: The 8th International Conference on Teaching Statistics–Data and Context in statistics education: Towards an evidence based society. International Statistical Institute, Voorburg2010.
21.
go back to reference Guo X, Guo D. A Nomogram based on comorbidities and infection location to Predict 30 days mortality of immunocompromised patients in ICU: a retrospective cohort study. Int J Gen Med. 2021;14:10281–92.CrossRefPubMedPubMedCentral Guo X, Guo D. A Nomogram based on comorbidities and infection location to Predict 30 days mortality of immunocompromised patients in ICU: a retrospective cohort study. Int J Gen Med. 2021;14:10281–92.CrossRefPubMedPubMedCentral
23.
go back to reference Xie T, Wang Y, Fu S, et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J. 2017;15(1):17.CrossRefPubMedPubMedCentral Xie T, Wang Y, Fu S, et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J. 2017;15(1):17.CrossRefPubMedPubMedCentral
24.
go back to reference Houshmand H, Farhadi R, Sedokani A. The evaluation of neutrophil to lymphocyte ratio in Kawasaki Disease and its value in Predicting IVIG Therapy Resistance. 2021. Houshmand H, Farhadi R, Sedokani A. The evaluation of neutrophil to lymphocyte ratio in Kawasaki Disease and its value in Predicting IVIG Therapy Resistance. 2021.
25.
go back to reference Lee ZM, Chu CL, Chu CH, Chang LS, Kuo HC. Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease. Pediatr Neonatol. 2022;63(2):117–24.CrossRefPubMed Lee ZM, Chu CL, Chu CH, Chang LS, Kuo HC. Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease. Pediatr Neonatol. 2022;63(2):117–24.CrossRefPubMed
26.
go back to reference Lu Y, Tang Y, Wang B, et al. Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio. Ital J Pediatr. 2022;48(1):208.CrossRefPubMedPubMedCentral Lu Y, Tang Y, Wang B, et al. Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio. Ital J Pediatr. 2022;48(1):208.CrossRefPubMedPubMedCentral
27.
go back to reference Kaji AH, Schriger D, Green S. Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies. Ann Emerg Med. 2014;64(3):292–8.CrossRefPubMed Kaji AH, Schriger D, Green S. Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies. Ann Emerg Med. 2014;64(3):292–8.CrossRefPubMed
Metadata
Title
Predictors and a novel predictive model for intravascular immunoglobulin resistance in Kawasaki disease
Authors
Junjie Wang
Xiaohui Huang
Donghao Guo
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Italian Journal of Pediatrics / Issue 1/2023
Electronic ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-023-01531-7

Other articles of this Issue 1/2023

Italian Journal of Pediatrics 1/2023 Go to the issue